COL6A3 and ovarian carcinoma: In 2003, Serial Analysis of Gene Expression (SAGE) sequencing of ovarian cancer cells with acquired resistance to cisplatin showed a 12-fold increase in COL6A3 mRNA in therapy-resistant cells compared with the parental lines [61].